Target intelligence / Profile preview

ATP-binding cassette transporter family (ABC transporter) (ABC transporter)

Target
ABC transporter
Molecular classification
Transporter, ATP-powered pump, Translocase
01

Overview

The ATP-binding cassette (ABC) transporter family is one of the largest and most ancient protein superfamilies, found in all extant phyla from bacteria to humans (Wikipedia, 2024; NIH, 2002). These transmembrane proteins utilize the energy of ATP binding and hydrolysis to actively transport a diverse array of substrates—including ions, lipids, sterols, metabolic products, and drugs—across cellular and organelle membranes (UniProt, 2024; IUPHAR, 2025). In humans, the family consists of 48-49 members divided into seven subfamilies (ABCA through ABCG), playing vital roles in physiological processes such as cholesterol homeostasis and the maintenance of the blood-brain barrier (NIH, 2002; Frontiers in Pharmacology, 2019). Clinically, ABC transporters are critical as they mediate the absorption and excretion of many drugs, and their overexpression is a primary mechanism of multidrug resistance (MDR) in cancer (NIH, 2024). Furthermore, mutations in ABC genes are linked to numerous genetic disorders, such as cystic fibrosis (CFTR/ABCC7), Tangier disease (ABCA1), and Stargardt disease (ABCA4) (NIH, 2002; ResearchGate, 2001).

Other names
ABC superfamilyTraffic ATPasesABC proteinsATP-powered pumps
02

Mechanism of action

ATP-dependent primary active transport of substrates across membranes; inhibition of efflux to reverse drug resistance; potentiation or correction of protein folding/function (e.g., CFTR modulators); regulation of ion channel activity (e.g., ABCC8/9).

03

Biological functions

Active transportLipid transportDrug effluxIon transportHomeostasisTranslationDNA repair
04

Disease associations

CancerCystic fibrosisTangier diseaseStargardt diseaseAdrenoleukodystrophyDubin-Johnson syndromeAlzheimer's diseaseCardiovascular disease
05

Safety considerations

Drug-drug interactions (DDIs) due to inhibition of protective barriers (BBB, gut)Systemic toxicity from impaired physiological transportOff-target effects on lipid homeostasisAcquired resistance in cancer
06

Interacting drugs

Ivacaftor

9 more in the full profile.

07

Biomarkers

ABCB1 (P-gp) expressionCFTR mutation status (e.g., F508del)ABCA1 levelsBilirubin levelsSerum bile acid levels

Beyond the preview

Go deeper on ATP-binding cassette transporter family (ABC transporter) (ABC transporter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette transporter family (ABC transporter) (ABC transporter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call